Nippon India Pharma Fund vs UTI Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8569 Cr | ₹1099 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 28% |
Expense Ratio | 1.82 | 2.22 |
Manager | Sailesh Raj Bhan | Kamal Gada |
ISIN Code | INF204K01968 | INF789F01695 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | 2.59% | 4.12% |
6 Month | 10.5% | 9.58% |
1 Year | 8.47% | 13.3% |
3 Year | 24.46% | 26.18% |
5 Year | 20.23% | 20.13% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 7.77% | 9.85% |
1 Year | 12.61% | 16.04% |
3 Year | 25.2% | 29.11% |
5 Year | 20.43% | 21.91% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 17.31% | 12.22% |
3 Year | 20.52% | 16.31% |
5 Year | 20.64% | 14.54% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 14.75% | 15.52% |
Sharp | 1.20% | 1.21% |
Beta | 0.90% | 0.95% |
Alpha | 0.72% | 0.74% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Sailesh Raj Bhan | Kamal Gada |
Total AUM | ₹96086 Cr | ₹870 Cr |
Funds Managed | 5 | 1 |
Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 0.53 | 2.96 |
Large Cap | 35.06 | 24.42 |
Mid Cap | 31.99 | 31 |
Small Cap | 32.41 | 41.62 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 0.53 | 1.1 |
Healthcare | 99.47 | 97.97 |
Basic Materials | - | 0.93 |
Top Comparisons
FRANKLIN INDIA MONEY MARKET FUND-GROWTH
3Y Returns7.41%
Tata Money Market Fund-Regular Plan - Growth Option
3Y Returns7.51%
LIC MF Ultra Short Term Fund Regular - Growth
3Y Returns6.41%
UTI Ultra Short Duration Fund- Regular Plan - Growth Option
3Y Returns6.83%
Sundaram ELSS Tax Saver Fund Regular Growth
3Y Returns16.14%
Sundaram Tax Savings Fund (Formerly Known as Principal Tax Savings Fund) Regular Growth
3Y Returns16.14%
Aditya Birla Sun Life Banking and Financial Services Fund - Regular Plan - Growth
3Y Returns17.34%
Baroda BNP Paribas Banking and Financial Services Fund - Regular - Growth Option
3Y Returns17.87%